lxr
biotechnology
said
wednesday
kenneth
mcguire
increased
holdings
company
9.3
percent
18.4
percent.in
private
transactions
company
said
mcguire
purchased
1,974,000
shares
common
stock
biotechnology
investment
group
llc
certain
trusts.mcguire
private
investor
principal
stockholder
position
number
biotechnology
companies
welcome
ken
mcguire
purchases
stock
said
dr
l
david
tomei
chief
executive
officer
lxr
ken
supportive
company
past
year
look
forward
working
closely
ahead
